Eosinophils are the most characteristic inflammatory cells in the airway mu
cosa in asthma. Eosinophils release highly toxic products and cytokines whi
ch may influence the immune system, amplify the inflammatory response and p
articipate in damaging and remodeling processes that occur in the airway mu
cosa. Eosinophilic inflammation in asthma is related to the blunted percept
ion of bronchoconstriction. The magnitude of eosinophil influx and the degr
ee of activation of these cells in the airway mucosa are related to the sev
erity of asthma and appear to play a key role in some eases of asthma death
. The number and activation of eosinophils in the airway mucosa are related
to the magnitude of airway hyperresponsiveness to bradykinin but not to an
agonist acting directly on smooth muscle such as methacholine. Inhaled cor
ticosteroids reduce eosinophil inflammation in asthma whereas beta 2-agonis
ts appear to increase the magnitude of eosinophilic inflammation induced hv
allergen exposure. The eosinophilic inflammation can he assessed by non-in
vasive methods using sputum analysis and, indirectly by measuring the airwa
y reactivity to bradykinin.